A credit-card library approach for disrupting protein–protein interactions

Functional organization of the yeast proteome by systematic analysis of protein complexes

Gavin, A., Böesche, M., Krause, R., Grandi, P., Marzioch, M., Bauer, A., Schultz, J., Rick, J. M., Michon, A., Cruciat, C., et al. (2002) · Nature · doi:10.1038/415141a · Cited by 4,729 · see citing works

Multicomponent Reactions with Isocyanides

Dömling, A. S. S., & Ugi, I. (2000) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20000915)39:18 · Cited by 4,079 · see citing works

Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry

Ho, Y., Gruhler, A., Heilbut, A. M., Bader, G. D., Moore, L., Adams, S., Millar, A., Taylor, P. P., Bennett, K. L., Boutilier, K., et al. (2002) · Nature · doi:10.1038/415180a · Cited by 3,573 · see citing works

Principles of protein-protein interactions

Jones, S., & Thornton, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.13 · Cited by 2,684 · see citing works

Anatomy of hot spots in protein interfaces

Bogan, A. A., & Thorn, K. S. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1843 · Cited by 1,988 · see citing works

The atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht

Conte, L. L., Chothia, C., & Janin, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2439 · Cited by 1,967 · see citing works

Small-molecule inhibitors of protein–protein interactions: progressing towards the dream

Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705 · see citing works

Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with Myc

Blackwood, E. M., & Eisenman, R. N. (1991) · Science · doi:10.1126/science.2006410 · Cited by 1,681 · see citing works

A Planning Strategy for Diversity‐Oriented Synthesis

Burke, M. D., & Schreiber, S. L. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200300626 · Cited by 1,493 · see citing works

Shape Complementarity at Protein/Protein Interfaces

Lawrence, M. C., & Colman, P. M. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1648 · Cited by 1,219 · see citing works

Shape complementarity at protein–protein interfaces

Norel, R., Lin, S. L., Wolfson, H. J., & Nussinov, R. (1994) · Biopolymers · doi:10.1002/bip.360340711 · Cited by 1,208 · see citing works

Applications of Combinatorial Technologies to Drug Discovery. 1. Background and Peptide Combinatorial Libraries

Gallop, M. A., Barrett, R. W., Dower, W. J., Fodor, S. P. A., & Gordon, E. M. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00035a001 · Cited by 1,135 · see citing works

Unraveling hot spots in binding interfaces: progress and challenges

DeLano, W. L. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00283-x · Cited by 767 · see citing works

A natural classification of the basic helix–loop–helix class of transcription factors

Atchley, W. R., & Fitch, W. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5172 · Cited by 686 · see citing works

Combinatorial synthesis — the design of compound libraries and their application to drug discovery

Terrett, N. K., Gardner, M., Gordon, D. W., Kobylecki, R. J., & Steele, J. (1995) · Tetrahedron · doi:10.1016/0040-4020(95)00467-m · Cited by 660 · see citing works

A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death

Li, L., Thomas, R., Suzuki, H., Brabander, J. D., Wang, X.-D., & Harran, P. G. (2004) · Science · doi:10.1126/science.1098231 · Cited by 620 · see citing works

Multicomponent one-pot annulations forming 3 to 6 bonds

Posner, G. H. (1986) · Chemical Reviews · doi:10.1021/cr00075a007 · Cited by 581 · see citing works

Oncogenic activity of the c-Myc protein requires dimerization with Max

Amati, B. B., Brooks, M. W., Levy-Strumpf, N., Littlewood, T. D., Evan, G. I., & Land, H. (1993) · Cell · doi:10.1016/0092-8674(93)90663-b · Cited by 559 · see citing works

Protein−Protein Interactions: Interface Structure, Binding Thermodynamics, and Mutational Analysis

Stites, W. E. (1997) · Chemical Reviews · doi:10.1021/cr960387h · Cited by 491 · see citing works

Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis

Bowman, T., Broome, M. A., Sinibaldi, D., Wharton, W., Pledger, W. J., Sedivy, J. M., Irby, R., Yeatman, T., Courtneidge, S. A., & Jove, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131568898 · Cited by 488 · see citing works

A general and expedient method for the solid-phase synthesis of 1,4-benzodiazepine derivatives

Bunin, B. A., & Ellman, J. A. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00053a067 · Cited by 443 · see citing works

Low molecular weight inhibitors of Myc–Max interaction and function

Yin, X., Giap, C., Lazo, J. S., & Prochownik, E. V. (2003) · Oncogene · doi:10.1038/sj.onc.1206641 · Cited by 426 · see citing works

Myc and Max associate in vivo.Preprint

Blackwood, E. M., Lüscher, B., & Eisenman, R. N. (1992) · Genes & Development · doi:10.1101/gad.6.1.71 · Cited by 415 · see citing works

The c‐Myc protein induces cell cycle progression and apoptosis through dimerization with Max.

Amati, B. B., Littlewood, T. D., Evan, G. I., & Land, H. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06202.x · Cited by 384 · see citing works

Function of the c-Myc Oncogenic Transcription Factor

Dang, C. V., Resar, L. M. S., Emison, E. S., Kim, S., Li, Q., Prescott, J. E., Wonsey, D. R., & Zeller, K. I. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4686 · Cited by 377 · see citing works

Binding of small molecules to an adaptive protein–protein interface

Arkin, M. R., Randal, M., DeLano, W. L., Hyde, J., Luong, T. N., Oslob, J. D., Raphael, D. R., Taylor, L., Wang, J., McDowell, R. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252756299 · Cited by 376 · see citing works

"Diversomers": an approach to nonpeptide, nonoligomeric chemical diversity.

DeWitt, S. H., Kiely, J. S., Stankovic, C. J., Schroeder, M. C., Cody, D. M., & Pavia, M. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.6909 · Cited by 340 · see citing works

Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts

Berg, T., Cohen, S. B., Desharnais, J., Sonderegger, C. K., Maslyar, D. J., Goldberg, J., Boger, D. L., & Vogt, P. K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062036999 · Cited by 326 · see citing works

Protein flexibility and drug design: how to hit a moving target

Carlson, H. A. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00341-1 · Cited by 314 · see citing works

Modulation of Protein–Protein Interactions with Small Organic Molecules

Berg, T. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200558 · Cited by 292 · see citing works

BiGGER: A new (soft) docking algorithm for predicting protein interactions

Palma, P. N., Krippahl, L., Wampler, J. E., & Moura, J. J. G. (2000) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(20000601)39:4 · Cited by 292 · see citing works

Neuere Methoden der präparativen organischen Chemie IV Mit Sekundär‐Reaktionen gekoppelte α‐Additionen von Immonium‐Ionen und Anionen an Isonitrile

Ugi, I. (1962) · Angewandte Chemie · doi:10.1002/ange.19620740103 · Cited by 266 · see citing works

Antagonists of protein–protein interactions

Cochran, A. G. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00106-x · Cited by 228 · see citing works

Involvement of the 'leucine zipper' region in the oligomerization and transforming activity of human c-myc protein

Dang, C. V., McGuire, M., Buckmire, M., & Lee, W. M. F. (1989) · Nature · doi:10.1038/337664a0 · Cited by 193 · see citing works

Solution‐Phase Combinatorial Libraries: Modulating Cellular Signaling by Targeting Protein–Protein or Protein–DNA Interactions

Boger, D. L., Desharnais, J., & Capps, K. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200300574 · Cited by 171 · see citing works

Small Molecule Affinity Fingerprinting

Greenbaum, D. C., Arnold, W. D., Lu, F., Hayrapetian, L., Baruch, A., Krumrine, J. R., Toba, S., Chehade, K. A. H., Brömme, D., Kuntz, I. D., et al. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00238-7 · Cited by 168 · see citing works

Diversity-Oriented Synthesis of Biaryl-Containing Medium Rings Using a One Bead/One Stock Solution Platform

Spring, D. R., Krishnan, S., Blackwell, H. E., & Schreiber, S. L. (2002) · Journal of the American Chemical Society · doi:10.1021/ja017248o · Cited by 165 · see citing works

The RNA of avian acute leukemia virus MC29.

DUESBERG, P. H., Bister, K., & Vogt, P. K. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.10.4320 · Cited by 157 · see citing works

Neue Darstellungsmethode für Isonitrile

Ugi, I., & Meyr, R. (1958) · Angewandte Chemie · doi:10.1002/ange.19580702213 · Cited by 151 · see citing works

Synthesis of 7200 Small Molecules Based on a Substructural Analysis of the Histone Deacetylase Inhibitors Trichostatin and Trapoxin

Sternson, S. M., Wong, J. C., Grozinger, C. M., & Schreiber, S. L. (2001) · Organic Letters · doi:10.1021/ol016915f · Cited by 139 · see citing works

Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements.

Harrison, S. C., Ferrer, M., Kapoor, T. M., Strassmaier, T., Weissenhorn, W., Skehel, J. J., Oprian, D., Schreiber, S. L., & Wiley, D. C. (1999) · Nature Structural Biology · doi:10.1038/13324 · Cited by 138 · see citing works

A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity

Parniak, M. A., Min, K., Budihas, S. R., Grice, S. F. J. L., & Beutler, J. A. (2003) · Analytical Biochemistry · doi:10.1016/j.ab.2003.06.001 · Cited by 127 · see citing works

c-MYC apoptotic function is mediated by NRF-1 target genesPreprint

Morrish, F. M., Giedt, C. D., & Hockenbery, D. M. (2003) · Genes & Development · doi:10.1101/gad.1032503 · Cited by 123 · see citing works

The generation of molecular diversity

Pavia, M. R., Sawyer, T. K., & Moos, W. H. (1993) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)80220-1 · Cited by 115 · see citing works

Protein functional epitopes: hot spots, dynamics and combinatorial libraries

Ma, B., Wolfson, H. J., & Nussinov, R. (2001) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00216-5 · Cited by 111 · see citing works

Avian acute leukemia viruses MC29 and MH2 share specific RNA sequences: Evidence for a second class of transforming genes

DUESBERG, P. H., & Vogt, P. K. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.4.1633 · Cited by 110 · see citing works

Preferential Heterodimeric Parallel Coiled-coil Formation by Synthetic Max and c-Myc Leucine Zippers: A Description of Putative Electrostatic Interactions Responsible for the Specificity of Heterodimerization

Lavigne, P., Kondejewski, L. H., Houston, M. E., Jr., Sönnichsen, F. D., Lix, B., Sykes, B. D., Hodges, R. S., & Kay, C. M. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0634 · Cited by 109 · see citing works

Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper

Lavigne, P., Crump, M. P., Gagné, S. M., Hodges, R. S., Kay, C. M., & Sykes, B. D. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1914 · Cited by 109 · see citing works

Tagged versus untagged libraries: methods for the generation and screening of combinatorial chemical libraries.

Janda, K. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10779 · Cited by 106 · see citing works

Protein–protein interactions: mechanisms and modification by drugs

Veselovsky, A. V., Ivanov, Y. D., Ivanov, A. S., Archakov, A. I., Lewi, P. J., & Janssen, P. (2002) · Journal of Molecular Recognition · doi:10.1002/jmr.597 · Cited by 102 · see citing works

High Throughput Screening via Mass Spectrometry: A Case Study Using Acetylcholinesterase

Özbal, C. C., LaMarr, W. A., Linton, J. R., Green, D. F., Katz, A., Morrison, T. B., & Brenan, C. J. H. (2004) · Assay and Drug Development Technologies · doi:10.1089/adt.2004.2.373 · Cited by 81 · see citing works

Regulation of both apoptosis and cell survival by the v-Src oncoprotein

Johnson, D., Agochiya, M., Samejima, K., Earnshaw, W. C., Frame, M. C., & Wyke, J. A. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400700 · Cited by 78 · see citing works

Myc/Max and other helix-loop-helix/leucine zipper proteins bend DNA toward the minor groove.

Fisher, D. E., Parent, L. A., & Sharp, P. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.11779 · Cited by 77 · see citing works

Synthetic Strategy toward Skeletal Diversity via Solid‐Supported, Otherwise Unstable Reactive Intermediates

Taylor, S. J., Taylor, A. M., & Schreiber, S. L. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200353466 · Cited by 76 · see citing works

A solution-phase strategy for the synthesis of chemical libraries containing small organic molecules: A universal and dipeptide mimetic template

Cheng, S., Tarby, C. M., Comer, D. D., Williams, J. P., Caporale, L. H., Myers, P. L., & Boger, D. L. (1996) · Bioorganic & Medicinal Chemistry · doi:10.1016/0968-0896(96)00069-7 · Cited by 74 · see citing works

Structural and Mutational Analysis of Affinity-Inert Contact Residues at the Growth Hormone−Receptor Interface

Pearce, K. H., Ultsch, M. H., Kelley, R. F., de Vos, A. M., & Wells, J. A. (1996) · Biochemistry · doi:10.1021/bi960513b · Cited by 73 · see citing works

Identification of Potent Ras Signaling Inhibitors by Pathway‐Selective Phenotype‐Based Screening

Müller, O., Gourzoulidou, E., Carpintero, M., Karaguni, I., Langerak, A., Herrmann, C., Möröy, T., Klein‐Hitpaß, L., & Waldmann, H. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200352587 · Cited by 70 · see citing works

Genetic dissection of c-myc apoptotic pathways

Nesbit, C. E., Tersak, J. M., Grove, L. E., Drzal, A., Choi, H.-J., & Prochownik, E. V. (2000) · Oncogene · doi:10.1038/sj.onc.1203636 · Cited by 58 · see citing works

The Myc:Max Protein Complex and Cell Growth RegulationPreprint

Blackwood, E. M., Lüscher, B., Kretzner, L., & Eisenman, R. N. (1991) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1991.056.01.015 · Cited by 49 · see citing works

Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max.

Davis, L. J., & Halazonetis, T. D. (1993) · PubMed · Cited by 36 · see citing works

Role of Oncogenic Transcription Factor c-Myc in Cell Cycle Regulation, Apoptosis and Metabolism

Dang, C. V., & Lewis, B. C. (1997) · Journal of Biomedical Science · doi:10.1007/bf02258350 · Cited by 35 · see citing works

Symmetrical Bis(heteroarylmethoxyphenyl)alkylcarboxylic Acids as Inhibitors of Leukotriene Biosynthesis

Kolasa, T., Gunn, D., Bhatia, P. A., Basha, A., Craig, R. A., Stewart, A. O., Bouska, J. B., Harris, R. R., Hulkower, K. I., Malo, P. E., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000180n · Cited by 29 · see citing works

Lead discovery of quinoxalinediones as an inhibitor of dipeptidyl peptidase-IV (DPP-IV) by high-throughput screening

Cheon, H., Lee, C., Kim, B., & Hwang, K. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.02.065 · Cited by 16 · see citing works

Purification Strategies for Combinatorial and Parallel Chemistry

Edwards, P. J. (2003) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207033329832 · Cited by 15 · see citing works

Combinatorial Approaches in Anticancer Drug Discovery: Recent Advances in Design and Synthesis

Bhattacharyya, S. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372139 · Cited by 12 · see citing works

Design of screening libraries biased for pharmaceutical discovery

Koehler, R. T., & Villar, H. O. (2000) · Journal of Computational Chemistry · doi:10.1002/1096-987x(200010)21:13 · Cited by 8 · see citing works

Use of “Tethering” for the Identification of a Small Molecule that Binds to a Dynamic Hot Spot on the Interleukin‐2 Surface

Berg, T. (2004) · ChemBioChem · doi:10.1002/cbic.200400054 · Cited by 5 · see citing works

Understanding protein non-folding

Uversky, V. N., & Dunker, A. K. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.01.017 · Cited by 1,188 · see citing works

The Myc oncoprotein as a therapeutic target for human cancer

Vita, M. F., & Arsenian‐Henriksson, M. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.015 · Cited by 554 · see citing works

Modulators of Protein–Protein Interactions

Milroy, L.-G., Grossmann, T. N., Hennig, S., Brunsveld, L., & Ottmann, C. (2014) · Chemical Reviews · doi:10.1021/cr400698c · Cited by 497 · see citing works

Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy

Han, H., Jain, A. D., Truica, M. I., Izquierdo-Ferrer, J., Anker, J. F., Lysy, B., Sagar, V., Luan, Y., Chalmers, Z. R., Unno, K., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.10.001 · Cited by 461 · see citing works

Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc

Madden, S. K., de Araujo, A. D., Gerhardt, M., Fairlie, D. P., & Mason, J. M. (2021) · Molecular Cancer · doi:10.1186/s12943-020-01291-6 · Cited by 404 · see citing works

Intrinsically disordered proteins are potential drug targets

Metallo, S. J. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.06.169 · Cited by 298 · see citing works

Strategies to Inhibit Myc and Their Clinical Applicability

Whitfield, J. R., Beaulieu, M.-È., & Soucek, L. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00010 · Cited by 295 · see citing works

Pathological Unfoldomics of Uncontrolled Chaos: Intrinsically Disordered Proteins and Human Diseases

Uversky, V. N., Davé, V., Iakoucheva, L. M., Malaney, P., Metallo, S. J., Pathak, R. R., & Joerger, A. C. (2014) · Chemical Reviews · doi:10.1021/cr400713r · Cited by 288 · see citing works

Features of protein–protein interactions that translate into potent inhibitors: topology, surface area and affinity

Smith, M. C. P., & Gestwicki, J. E. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2012.10 · Cited by 285 · see citing works

A Molecular Link between the Active Component of Marijuana and Alzheimer's Disease Pathology

Eubanks, L. M., Rogers, C. J., Beuscher, Koob, G. F., Olson, A. J., Dickerson, T. J., & Janda, K. D. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060066m · Cited by 270 · see citing works

Targeting Protein–Protein Interactions for Therapeutic Intervention: A Challenge for the Future

Zinzalla, G., & Thurston, D. E. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.12 · Cited by 257 · see citing works

Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics

Chen, B.-J., Wu, Y., Tanaka, Y., & Zhang, W. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.10190 · Cited by 247 · see citing works

MYC in Oncogenesis and as a Target for Cancer Therapies

Albihn, A., Johnsen, J. I., & Arsenian‐Henriksson, M. (2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)07006-5 · Cited by 240 · see citing works

Multiple Independent Binding Sites for Small-Molecule Inhibitors on the Oncoprotein c-Myc

Hammoudeh, D. I., Follis, A. V., Prochownik, E. V., & Metallo, S. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja900616b · Cited by 232 · see citing works

Therapeutic Strategies to Inhibit MYCPreprint

McKeown, M. R., & Bradner, J. E. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014266 · Cited by 226 · see citing works

MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies

Ahmadi, S. E., Rahimi, S., Zarandi, B., Chegeni, R., & Safa, M. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01111-4 · Cited by 211 · see citing works

Two decades of recent advances of Ugi reactions: synthetic and pharmaceutical applications

Fouad, M. A., Abdel‐Hamid, H., & Ayoup, M. S. (2020) · RSC Advances · doi:10.1039/d0ra07501a · Cited by 200 · see citing works

A complex task? Direct modulation of transcription factors with small molecules

Koehler, A. N. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.03.022 · Cited by 189 · see citing works

Structural Rationale for the Coupled Binding and Unfolding of the c-Myc Oncoprotein by Small Molecules

Follis, A. V., Hammoudeh, D. I., Wang, H., Prochownik, E. V., & Metallo, S. J. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.09.011 · Cited by 183 · see citing works

Small-molecule inhibitors of the Myc oncoprotein

Fletcher, S., & Prochownik, E. V. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.03.005 · Cited by 153 · see citing works

Therapeutic Targeting of Myc

Prochownik, E. V., & Vogt, P. K. (2010) · Genes & Cancer · doi:10.1177/1947601910377494 · Cited by 150 · see citing works

Selective Inhibition of c-Myc/Max Dimerization and DNA Binding by Small Molecules

Kiessling, A., Sperl, B., Hollis, A., Eick, D., & Berg, T. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.05.011 · Cited by 148 · see citing works

Design, Synthesis, and Evaluation of an α-Helix Mimetic Library Targeting Protein−Protein Interactions

Shaginian, A., Whitby, L. R., Hong, S., Hwang, I., Farooqi, B., Searcey, M., Chen, J., Vogt, P. K., & Boger, D. L. (2009) · Journal of the American Chemical Society · doi:10.1021/ja810025g · Cited by 144 · see citing works

Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D2concept

Uversky, V. N. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.36 · Cited by 141 · see citing works

An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists

Eubanks, L. M., Hixon, M. S., Jin, W., Hong, S., Clancy, C. M., Tepp, W. H., Baldwin, M. R., Malizio, C. J., Goodnough, M. C., Barbieri, J. T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611213104 · Cited by 123 · see citing works

In Vitro Cytotoxicity and In Vivo Efficacy, Pharmacokinetics, and Metabolism of 10074-G5, a Novel Small-Molecule Inhibitor of c-Myc/Max Dimerization

Clausen, D. M., Guo, J., Parise, R. A., Beumer, J. H., Egorin, M. J., Lazo, J. S., Prochownik, E. V., & Eiseman, J. L. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.170555 · Cited by 117 · see citing works

Inhibition of transcription factors with small organic molecules

Berg, T. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.07.023 · Cited by 115 · see citing works

Structural and Biophysical Insights into the Function of the Intrinsically Disordered Myc Oncoprotein

Beaulieu, M.-È., Castillo, F., & Soucek, L. (2020) · Cells · doi:10.3390/cells9041038 · Cited by 110 · see citing works

Targeting intrinsically disordered proteins involved in cancer

Santofimia‐Castaño, P., Rizzuti, B., Xia, Y., Abián, O., Peng, L., Velázquez‐Campoy, A., Neira, J. L., & Iovanna, J. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03347-3 · Cited by 110 · see citing works

Perturbation of the c-Myc–Max Protein–Protein Interaction via Synthetic α-Helix Mimetics

Jung, K., Wang, H., Teriete, P., Yap, J. L., Chen, L., Lanning, M. E., Hu, A., Lambert, L. J., Holien, T., Sundan, A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501440q · Cited by 94 · see citing works

Selective antagonism of cJun for cancer therapy

Brennan, A., Leech, J. T., Kad, N. M., & Mason, J. M. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01686-9 · Cited by 91 · see citing works

Pharmacophore identification of c-Myc inhibitor 10074-G5

Yap, J. L., Wang, H., Hu, A., Chauhan, J., Jung, K.-Y., Gharavi, R. B., Prochownik, E. V., & Fletcher, S. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.10.013 · Cited by 83 · see citing works

Selective Inhibition of c‐Myc/Max Dimerization by a Pyrazolo[1,5‐a]pyrimidine

Kiessling, A., Wiesinger, R., Sperl, B., & Berg, T. (2007) · ChemMedChem · doi:10.1002/cmdc.200600294 · Cited by 83 · see citing works

Comprehensive Survey of Chemical Libraries for Drug Discovery and Chemical Biology: 2006

Dolle, R. E., Bourdonnec, B. L., Goodman, A. J., Morales, G. A., Salvino, J. M., & Zhang, W. (2007) · Journal of Combinatorial Chemistry · doi:10.1021/cc700111e · Cited by 82 · see citing works

A Leap into the Chemical Space of Protein-Protein Interaction Inhibitors

Villoutreix, B. O., Labbé, C. M., Lagorce, D., Laconde, G., & Spérandio, O. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802651571 · Cited by 68 · see citing works

Small Molecule Modulators of Transcription

Arndt, H. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600285 · Cited by 68 · see citing works

Embryonal neural tumours and cell death

Johnsen, J. I., Kogner, P., Albihn, A., & Arsenian‐Henriksson, M. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0325-y · Cited by 67 · see citing works

Methods of probing the interactions between small molecules and disordered proteins

Heller, G. T., Aprile, F. A., & Vendruscolo, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2563-4 · Cited by 62 · see citing works

Stabilizers of the Max Homodimer Identified in Virtual Ligand Screening Inhibit Myc Function

Jiang, H., Bower, K. E., Beuscher, A. E., Zhou, B., Bobkov, A. A., Olson, A. J., & Vogt, P. K. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.054858 · Cited by 62 · see citing works

Small-molecule perturbation of competing interactions between c-Myc and Max

Follis, A. V., Hammoudeh, D. I., Daab, A. T., & Metallo, S. J. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.025 · Cited by 60 · see citing works

Small molecule inhibitors of Myc/Max dimerization and Myc-induced cell transformation

Jin, S. K., Stover, J. S., Whitby, L. R., Vogt, P. K., & Boger, D. L. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.044 · Cited by 59 · see citing works

A Small Molecule Stabilizes the Disordered Native State of the Alzheimer’s Aβ Peptide

Löhr, T., Kohlhoff, K. J., Heller, G. T., Camilloni, C., & Vendruscolo, M. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00116 · Cited by 50 · see citing works

Inhibition of the ALDH18A1-MYCN positive feedback loop attenuates MYCN -amplified neuroblastoma growth

Guo, Y.-F., Duan, J., Wang, J., Li, L., Wang, D., Liu, X.-Z., Yang, J., Zhang, H., Lv, J., Yang, Y., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax8694 · Cited by 52 · see citing works

Small-Molecule Modulators of c-Myc/Max and Max/Max Interactions

Berg, T. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_90 · Cited by 52 · see citing works

Discovery of Methyl 4′‐Methyl‐5‐(7‐nitrobenzo[ c ][1,2,5]oxadiazol‐4‐yl)‐[1,1′‐biphenyl]‐3‐carboxylate, an Improved Small‐Molecule Inhibitor of c‐Myc–Max Dimerization

Chauhan, J., Wang, H., Yap, J. L., Sabato, P. E., Hu, A., Prochownik, E. V., & Fletcher, S. (2014) · ChemMedChem · doi:10.1002/cmdc.201402189 · Cited by 49 · see citing works

Targeting the Wolbachia Cell Division Protein FtsZ as a New Approach for Antifilarial Therapy

Li, Z., Garner, A. L., Gloeckner, C., Janda, K. D., & Carlow, C. K. S. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001411 · Cited by 49 · see citing works

A small molecule antagonist of ghrelin O-acyltransferase (GOAT)

Garner, A. L., & Janda, K. D. (2011) · Chemical Communications · doi:10.1039/c1cc11817j · Cited by 48 · see citing works

Identification of Inhibitors of Biological Interactions Involving Intrinsically Disordered Proteins

Marasco, D., & Scognamiglio, P. L. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16047394 · Cited by 42 · see citing works

Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer

Fairlie, W. D., & Lee, E. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062841 · Cited by 43 · see citing works

MYC the oncogene from hell: Novel opportunities for cancer therapy

Papadimitropoulou, A., Makri, M., & Zoidis, G. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116194 · Cited by 38 · see citing works

Proteomic Approaches in Understanding Action Mechanisms of Metal-Based Anticancer Drugs

Wang, Y., & Chiu, J. (2008) · Metal-Based Drugs · doi:10.1155/2008/716329 · Cited by 37 · see citing works

Gene Transactivation and Transrepression in MYC-Driven Cancers

Scafuro, M., Capasso, L., Carafa, V., Altucci, L., & Nebbioso, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073458 · Cited by 34 · see citing works

Small-molecule inhibitors of dimeric transcription factors: Antagonism of protein–protein and protein–DNA interactions

Yap, J. L., Chauhan, J., Jung, K., Chen, L., Prochownik, E. V., & Fletcher, S. (2012) · MedChemComm · doi:10.1039/c2md00289b · Cited by 32 · see citing works

Intrinsic Protein Flexibility in Regulation of Cell Proliferation: Advantages for Signaling and Opportunities for Novel Therapeutics

Follis, A. V., Galea, C. A., & Kriwacki, R. W. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0659-4_3 · Cited by 31 · see citing works

Evaluation of “Credit Card” Libraries for Inhibition of HIV-1 gp41 Fusogenic Core Formation

Xu, Y. Y., Lü, H., Kennedy, J. P., Yan, X., McAllister, L. A., Yamamoto, N., Moss, J. A., Boldt, G. E., Jiang, S., & Janda, K. D. (2006) · Journal of Combinatorial Chemistry · doi:10.1021/cc0600167 · Cited by 31 · see citing works

Multiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastoma

Tsigelny, I. F., Mukthavaram, R., Kouznetsova, V. L., Chao, Y. S., Babić, I., Nurmemmedov, E., Pastorino, S., Jiang, P., Calligaris, D., Agar, N. Y. R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5633 · Cited by 29 · see citing works

Inhibition of a protein‐protein interaction between INI1 and c‐Myc by small peptidomimetic molecules inspired by Helix‐1 of c‐Myc: identification of a new target of potential antineoplastic interest

Bagnasco, L., Tortolina, L., Biasotti, B., Castagnino, N., Ponassi, R., Tomati, V., Nieddu, E., Stier, G., Malacarne, D., & Parodi, S. (2007) · The FASEB Journal · doi:10.1096/fj.06-7082com · Cited by 28 · see citing works

Breaking Tolerance in a Mouse Model of Multiple Myeloma by Chemoimmunotherapy

Sharabi, A., & Haran‐Ghera, N. (2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)07001-6 · Cited by 27 · see citing works

Kleine Moleküle als Transkriptionsmodulatoren

Arndt, H. (2006) · Angewandte Chemie · doi:10.1002/ange.200600285 · Cited by 20 · see citing works

Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity

Miranda, P. O., Cubitt, B., Jacob, N. T., Janda, K. D., & de la Torre, J. C. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00236 · Cited by 19 · see citing works

Synthesis and evaluation of a library of 2,5-bisdiamino-benzoquinone derivatives as probes to modulate protein–protein interactions in prions

Tran, H. N. A., Bongarzone, S., Carloni, P., Legname, G., & Bolognesi, M. L. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.149 · Cited by 19 · see citing works

Selective targeting of MYC mRNA by stabilized antisense oligonucleotides

Gill, T., Wang, H., Bandaru, R., Lawlor, M. A., Lu, C., Nieman, L. T., Tao, J., Zhang, Y., Anderson, D. G., Ting, D. T., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02053-4 · Cited by 18 · see citing works

Development of a High-Throughput Screen and Its Use in the Discovery of Streptococcus pneumoniae Immunoglobulin A1 Protease Inhibitors

Garner, A. L., Fullagar, J. L., Day, J. A., Cohen, S. M., & Janda, K. D. (2013) · Journal of the American Chemical Society · doi:10.1021/ja404180x · Cited by 18 · see citing works

12 Arylstibonic acids that inhibit the DNA binding of five B-ZIP dimers

Rishi, V., Oh, W., Heyerdahl, S. L., Zhao, J., Scudiero, D. A., Shoemaker, R. H., & Vinson, C. (2010) · Journal of Structural Biology · doi:10.1016/j.jsb.2010.02.013 · Cited by 16 · see citing works

Vpu Matchmakers as a Therapeutic Strategy for HIV Infection

Montal, M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000246 · Cited by 16 · see citing works

Prediction of antiprion activity of therapeutic agents with structure–activity models

Venko, K., Župerl, Š., & Novič, M. (2013) · Molecular Diversity · doi:10.1007/s11030-013-9477-3 · Cited by 13 · see citing works

Posttranslational regulation of Myc by promyelocytic leukemia zinc finger protein

Jin, S. K., & Vogt, P. K. (2009) · International Journal of Cancer · doi:10.1002/ijc.24449 · Cited by 13 · see citing works

Identification of hub genes and their correlation with infiltration of immune cells in MYCN positive neuroblastoma based on WGCNA and LASSO algorithm

Chen, J., Sun, M., Chen, C., Jiang, B., & Fang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1016683 · Cited by 9 · see citing works

Association of a Novel Preribosomal Complex in Trypanosoma brucei Determined by Fluorescence Resonance Energy Transfer

Wang, L., Ciganda, M., & Williams, N. (2012) · Eukaryotic Cell · doi:10.1128/ec.00316-12 · Cited by 8 · see citing works

Discovery of 4-(4-(3-(1-(2-(piperidin-1-yl)ethyl)-1H-benzo[d]imidazole-2-yl)isoxazol-5-yl)phenyl)morpholine as a novel c-Myc inhibitor against lung cancer in vitro and in vivo

Gao, J. T., Yin, J., Li, S., Jia, P., Hong, R., Chen, J., Qu, X., Zhang, Z., Li, M., & Zhao, H. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117023 · Cited by 6 · see citing works

Protein–Protein Interaction Inhibitors in Cancer

Hardcastle, I. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12392-3 · Cited by 4 · see citing works

Identifying Critical Signaling Molecules for the Treatment of Cancer

Arvanitis, C., Bendapudi, P. K., Bachireddy, P., & Felsher, D. W. (2007) · Springer eBooks · doi:10.1007/978-3-540-31209-3_2 · Cited by 3 · see citing works

The use of small molecule probes to study spatially separated stimulus-induced signaling pathways

Kravchenko, V. V., Gloeckner, C., Stowe, G. N., Kang, Y. J., Tobias, P. S., Mathison, J. C., Ulevitch, R. J., Kaufmann, G. F., & Janda, K. D. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.01.024 · Cited by 2 · see citing works

Oncogenes and the Initiation and Maintenance of Tumorigenesis

Felsher, D. W., Arvanitis, C., Bendapudi, P. K., & Bachireddy, P. (2016) · Springer eBooks · doi:10.1007/978-1-59745-458-2_8 · Cited by 2 · see citing works

A Promising but Challenging Strategy for Cancer Treatment: Disruption of Myc-Max Heterodimerization

Kim, H., Yoo, M., & Jung, K.-Y. (2016) · International Journal of Clinical Pharmacology & Pharmacotherapy · doi:10.15344/2456-3501/2016/114 · Cited by 1 · see citing works

A small molecule stabilises the disordered native state of the Alzheimer’s Aβ peptidePreprint

Löhr, T., Kohlhoff, K. J., Heller, G. T., Camilloni, C., & Vendruscolo, M. (2021) · bioRxiv · doi:10.1101/2021.11.10.468059 · Cited by 2 · see citing works

A Leap into the Chemical Space of Protein–Protein Interaction Inhibitors

Villoutreix, B. O., Labbé, C. M., Lagorce, D., Laconde, G., & Spérandio, O. (2013) · Methods and principles in medicinal chemistry · doi:10.1002/9783527648207.ch4 · Cited by 1 · see citing works

A Novel Assay for the Quantification of Active Transcription Factors

Goodhand, I. M. (2011) · UPT. Syiah Kuala University Library (Syiah Kuala University)

High‐Throughput Methods of Chemical Synthesis Applied to the Preparation of Inhibitors of Protein–Protein Interactions

Franz, A. K., Shaw, J. T., & Tang, Y. (2010) · doi:10.1002/9780470972137.ch7

Counteracting inhibition of apoptosis by c-Myc, Bcl-2, and c-FLIP: A multifaceted approach to inducing cell death

Sheng, L. (2017) · Texas ScholarWorks (Texas Digital Library) · doi:10.15781/t26t0hb97

sarA as a Target for the Treatment and Prevention of Staphylococcal Biofilm-Associated Infection

Smeltzer, M. S. (2012) · doi:10.21236/ada576194

UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL CENTRO DE BIOTECNOLOGIA PROGRAMA DE PÓS-GRADUAÇÃO EM BIOLOGIA CELULAR E MOLECULAR ALVOS MOLECULARES EM MEDULOBLASTOMA:

Schmidt, A. L., & Alegre, P. (2010)

Synthetic Approaches and Challenges to Transcription Factor Inhibitors

Procopiou, G., & Procopiou, P. A. (2018) · Royal Society of Chemistry eBooks · doi:10.1039/9781782624011-00001

Small-molecule Inhibitors of Myc–Max Interaction and DNA Binding

Fletcher, S., & Prochownik, E. V. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016544-00302

Citations

(2006) · BioTechniques · doi:10.2144/000112185

Combinatorial Chemistry Online

Terrett, N. K. (2006) · Combinatorial Chemistry - an Online Journal · doi:10.1016/j.comche.2006.04.001

sarA as a Target for the Treatment and Prevention of Staphylococcal Biofilm-Associated Infection

Smeltzer, M. S. (2015) · doi:10.21236/ada621335

Nitroxyl Hybrids with Curcumin and Stilbene Scaffolds Display Potent Antioxidant Activity, Remodel the Amyloid Beta Oligomer, and Reverse Amyloid Beta-Induced Cytotoxicity

Budamagunta, M. S., Mori, H., Silk, J., Slez, R. R., Bognár, B., Mendiola, U. R., Kálai, T., Maezawa, I., & Voss, J. C. (2024) · Antioxidants · doi:10.3390/antiox13111411

Bases moleculars de l’activitat antitumoral de la lenalidomida en el limfoma de cèl•lules del mantell

Sanz, A. M. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

Structure et dynamique de protéines intrinsèquement désordonnées : Caractérisation par une approche combinant dynamique moléculaire avancée et SAXS

Chan-Yao-Chong, M. (2019) · doi:10.70675/6f405727zb0adz4df8zbcbazc9a3c3451b97

Chemical intervention strategies targeting MYC for cancer therapy

Wu, D., Zhu, Y., Ye, M., Guo, X., Jiang, Z., & Zhang, X. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104726

BindingDB Entry 50042315: Pharmacophore identification of c-Myc inhibitor 10074-G5.

BindingDB (2013) · UC San Diego · doi:10.7270/q2wm1fpm

BindingDB Entry 50006255: Perturbation of the c-Myc-Max protein-protein interaction via synthetic α-helix mimetics.

BindingDB (2020) · UC San Diego · doi:10.7270/q2w3809s

BindingDB Entry 50021153: MYC the oncogene from hell: Novel opportunities for cancer therapy.

BindingDB (2025) · UC San Diego · doi:10.7270/q2qz2gkz

BindingDB Entry 2676: An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists.

BindingDB (2008) · UC San Diego · doi:10.7270/q28050wn

Exploring a "Nature-Inspired" Strategy for Enhancing the Pharmacology of Small Molecules: Towards the Development of Next Generation Anti-Infectives.

Marinec, P. S. (2011)

Structure-guided screening of protein-protein interaction for the identification of Myc-Max heterodimer complex modulators

Bhowmick, S., Roy, K., & Saha, A. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2294174

2P2Ichem: focused chemical libraries dedicated to orthosteric modulation of protein–protein interactions

Hamon, V., Brunel, J. M., Combes, S., Basse, M. J., Roche, P., & Morelli, X. (2013) · MedChemComm · doi:10.1039/c3md00018d · Cited by 31 · see citing works

Targeting Protein-Protein Interactions- Inhibitors of c-Myc/Max and PDZ Domain Proteins

Bach, A., & Silas, D. T. (2014)

Les chimiothèques ciblant les interactions protéine-protéine

Spérandio, O., Villoutreix, B. O., Morelli, X., & Roche, P. (2015) · médecine/sciences · doi:10.1051/medsci/20153103017 · Cited by 5 · see citing works

Design, Optimization and Syntheses of Small Molecules to Disrupt Protein-Protein Interactions

Taechalertpaisarn, J. (2018) · OakTrust (Texas A&M University Libraries)